John Payne
CEO & Founder
Description:
Payne was appointed director on July 19, 2013. He brings more than 30 years’ experience in the global animal health industry to the HEPI board. Payne previously served as President and CEO of Banfield Pet Hospitals, leadership team member for Mars Global PetCare, and President and General Manager of Bayer Healthcare's North American Animal Health Division. Payne is also CEO and Founder of Pet Health Innovations, LLC. He has been honored for his commitment to bringing human quality medicine and healthcare to pets, and has gained worldwide recognition.
Summary:
Payne was appointed director on July 19, 2013. He brings more than 30 years’ experience in the global animal health industry to the HEPI boa...
Number of Registered Investments:1
Contact Details:
- Address: Washington, District of Columbia, United States
- No email is provided
Location:Washington, District of Columbia, United States
Email is Not Provided
Phone Number:Washington, District of Columbia, United States
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.